My Account Log in

1 option

The Role of Government Reimbursement in Drug Shortages / Ali Yurukoglu, Eli Liebman, David B. Ridley.

NBER Working papers Available online

View online
Format:
Book
Author/Creator:
Yurukoglu, Ali.
Contributor:
National Bureau of Economic Research.
Liebman, Eli.
Ridley, David B.
Series:
Working Paper Series (National Bureau of Economic Research) no. w17987.
NBER working paper series no. w17987
Language:
English
Physical Description:
1 online resource: illustrations (black and white);
Place of Publication:
Cambridge, Mass. National Bureau of Economic Research 2012.
Summary:
Beginning in the mid-2000s, the incidence of drug shortages rose, especially for generic injectable drugs such as anesthetics and chemotherapy treatments. We examine whether reimbursement changes contributed to the shortages, focusing on a reduction in Medicare Part B reimbursement to providers for drugs. We hypothesize that lower reimbursement put downward pressure on manufacturers' prices which reduced manufacturers' incentives to invest in capacity, reliability, and new launches. We show that, after the policy change, shortages rose more for drugs with (i) higher shares of patients insured by Medicare, (ii) greater decreases in provider reimbursement, and (iii) greater decreases in manufacturer prices.
Notes:
Print version record
April 2012.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account